Aquatic Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Aquatic Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541K	Buy	+11,624	New	+$558K	0.02%	770
2025 Q3	–	Sell	-31,484	Closed	-$992K	–	1658
2025 Q2	$992K	Sell	31,484 -684	-2%	-$21.9K	0.02%	647
2025 Q1	$1.05M	Buy	32,168 +31,342	+3,794%	+$1.11M	0.03%	590
2024 Q4	$29.9K	Sell	826 -1,974	-71%	-$69.5K	﹤0.01%	1216
2024 Q3	$87.3K	Buy	+2,800	New	+$87.4K	﹤0.01%	939
2024 Q1	–	Sell	-4,700	Closed	-$136K	–	1624
2023 Q4	$136K	Buy	+4,700	New	+$125K	﹤0.01%	940
2023 Q3	–	Sell	-19,600	Closed	-$589K	–	1633
2023 Q2	$589K	Buy	+19,600	New	+$686K	0.03%	417
2022 Q3	–	Sell	-200	Closed	-$6K	–	1532
2022 Q2	$6K	Buy	+200	New	+$5.73K	﹤0.01%	1035
2022 Q1	–	Sell	-100	Closed	-$3K	–	1503
2021 Q4	$3K	Buy	+100	New	+$3.03K	0.01%	1018

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Aquatic Capital Management's SUPN Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 11,624 shares worth $541K. The stake represents 0.02% of the portfolio and ranks #770 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in SUPN as recently as Q2 2025.

Aquatic Capital Management first reported a position in SUPN in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.05M in Q1 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Aquatic Capital Management held 11,624 shares of Supernus Pharmaceuticals worth $541K as of Q2 2026.
Supernus Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
Supernus Pharmaceuticals made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #770 holding.
Aquatic Capital Management first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Aquatic Capital Management's Supernus Pharmaceuticals position peaked at $1.05M in Q1 2025.
334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.